Drawing for CARELOG: SYMPTOM & MED TRACKER

USPTO serial 99727622

CARELOG: SYMPTOM & MED TRACKER

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
ELLIOTT, LASHAWNDA E
Law office
TMO LAW OFFICE 125

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Deadline: November 21, 2026

Need help with CARELOG: SYMPTOM & MED TRACKER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Office Action issues

The examiner refused registration because the trademark is considered descriptive of your goods and services, and also requires clarification of your product and service descriptions across multiple classes along with a conditional disclaimer.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile applications for recording, tracking, retrieving, and displaying personal health information, including symptoms, conditions, medications, mood, sleep quality, meals, vital signs, heart rate, weight, and height; downloadable mobile applications featuring voice notes, health tips, doctor appointment tracking, medication dosage and adherence tracking, and health data charts and trend reports; downloadable mobile applications that integrate with third-party health and fitness platformsACTIVE—
044Providing health information and wellness services via a mobile application; providing personalized health tips based on user-entered health data; online health management tools for tracking symptoms, conditions, medications, and medical appointments; providing a care circle network connecting patients with family members, friends, doctors, and caretakers via a mobile application; providing doctor visit summaries via a mobile applicationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Aug 21, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2026DOCKASSIGNED TO EXAMINER—
Aug 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 26, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 26, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance